RNAZ icon

TransCode Therapeutics
RNAZ

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $237K invested in TransCode Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$219K
2
+$2.71K
3
+$63
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$15

Top Sellers

1
-$724K
2
-$113K
3
-$62.4K
4
WAM
Warberg Asset Management
Illinois
-$24.8K
5
CCM
Corsair Capital Management
New York
-$19.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$219K
UBS Group
2
UBS Group
Switzerland
$11.2K
SC
3
SouthState Corp
Florida
$3.76K
TRCT
4
Tower Research Capital (TRC)
New York
$3.14K
SS
5
SBI Securities
Japan
$78
Bank of America
6
Bank of America
North Carolina
$63
Fidelity Investments
7
Fidelity Investments
Massachusetts
$23
AFM
8
Anson Funds Management
Texas
–
SM
9
Sabby Management
Florida
–
WAM
10
Warberg Asset Management
Illinois
–
CCM
11
Corsair Capital Management
New York
–
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
–
Commonwealth Equity Services
13
Commonwealth Equity Services
Massachusetts
–
GSC
14
Ground Swell Capital
South Carolina
–
Morgan Stanley
15
Morgan Stanley
New York
–
Osaic Holdings
16
Osaic Holdings
Arizona
–